Skip to main content
logo
Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
6.40
+0.15 (2.40%)
At close: Oct 20, 2025, 4:00 PM EDT
6.41
+0.01 (0.16%)
After-hours: Oct 20, 2025, 7:22 PM EDT

Capricor Therapeutics Revenue

Capricor Therapeutics had revenue of $13.39M in the twelve months ending June 30, 2025, down -50.68% year-over-year. In the year 2024, Capricor Therapeutics had annual revenue of $22.27M, down -11.55%.

Revenue (ttm)
$13.39M
Revenue Growth
-50.68%
P/S Ratio
19.72
Revenue / Employee
$83,701
Employees
160
Market Cap
292.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202422.27M-2.91M-11.55%
Dec 31, 202325.18M22.63M886.81%
Dec 31, 20222.55M2.31M941.85%
Dec 31, 2021244.90K-65.35K-21.06%
Dec 31, 2020310.25K-694.78K-69.13%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

CAPR News

More News